- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06098794
Effect of Sodium Bicarbonate on Exercise Performance
The Effects of Sodium Bicarbonate Supplementation on Intense Exercise Performance
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Experimental design: The study consisted of a randomized, double-blind, controlled, crossover trial where 11 female football players performed, in a randomized order, two repeated sprints tasks in a cycle ergometer, after having ingested either sodium bicarbonate (SB) or placebo (PL). Body composition of the athletes was characterized by bioelectrical impedance analysis with a single frequency (50 kHz) device (BIA 101 Anniversary, Akern, Florence, Italy) before the exercise sessions. Data collection was separated by a period of at least one week within a period of time not exceeding one month and performed at the same time of the day for each participant. Data regarding performance, blood lactate accumulation, pulmonary gas exchange, heart rate (HR), muscle oxygenation and neuromuscular fatigue were collected during these two sessions.
Supplementation protocol: The participants ingested capsules containing 0.3 g/kg of body weight of SB or cellulose as PL divided into two doses. The first intake (0.2 g/kg) occurred 2 h before the beginning of the protocol, and the second (0.1 g/kg) occurred 1 h later. Possible gastrointestinal symptoms associated with supplement ingestion were controlled with a questionnaire based on the questionnaire applied by Miller et al. (2016).
Repeated sprints protocol: The RSA protocol was performed in a cycle ergometer (Monark Ergomedic 894 E, Monark Exercise AB, Vansbro, Sweden) and was composed of 3 sets of 6 sprints with 6 s duration with a workload of 4% of the body mass. Repetitions were separated by 24 s of active recovery, and participants were conceded 5 min of passive recovery to rest between sets. The protocol was preceded by a 5-min warm-up in which athletes pedalled at a speed of 60 to 70 rpm.
Performance Measurements: Performance was evaluated by monitoring peak power output, mean power output, total work and the sprint decrement in each set of the two repeated sprints task.
Blood lactate accumulation: Lactate concentration was assessed (Lactate Pro 2, KDK Corporation, Kyoto, Japan) in capillary blood from the ear lobe before the beginning of each protocol, 1 min after the end of each set, and at min 1 and every 2 min after the tasks were completed, until the value started to decrease. At the end of the tasks, the maximal values achieved were considered for analysis.
Pulmonary gas exchange and heart rate: Oxygen uptake, carbon dioxide production and ventilation (VO2, VCO2, VE, respectively) were measured breath-by-breath, during the protocol, using a gas analyser (MetaMax 3B, Cortex Biophysik, Leipzig, Germany). Heart rate was continuously evaluated using an HR monitor (H7, Polar Electro Oy, Kempele, Finland). The integral of VO2 (L) and VCO2 (L) and the maximum 6-s moving average of relative VO2 (mL/kg.min), VE (L/min) and HR (bpm) were calculated for each set.
Muscle oxygenation: Throughout the protocol, oxygenated (O2Hb) and deoxygenated haemoglobin (HHb) were continuously monitored with a near-infrared spectroscopy device (Niro-200NX, Hamamatsu Phototonics, Hamamatsu, Japan) according with the manufacturer specifications. The integrals of O2Hb and HHb were calculated for each set of the protocol.
Neuromuscular fatigue assessment: Athletes executed a countermovement jump (CMJ) in a contact mat (Chronojump BoscoSystem, Software Version 2.2.0, Barcelona, Spain) before and after the exercise protocol, accessing values of jump height (JH). Three jumps were performed, separated by 30 s of rest, and the best jump was considered for analysis.
Data analysis: Power and sample calculations (G-Power, Version 3.1.9.2, Düsseldorf, Germany) were based on an effect size of 0.88 (McNaughton et al., 1997) for total work performed in the sprints, a power of 0.85 and a significance of 0.05. After the recruitment process, 12 athletes volunteered to participate in the study. One volunteer withdrew due to injury, leading to a sample size of 11 athletes. Statistical analysis was performed using the Statistical Package for the Social Sciences (IBM Corp, SPSS v27.0, Armonk, NY, USA) and R software (v4.2.0, Open-Source Code, General Public License). Normal distribution and sphericity were tested using Shapiro-Wilk's and Mauchly's tests, respectively. For variables with normal distribution, data was analysed using a two-way analysis of variance (ANOVA). Whenever a statistical significance was observed in the two-way ANOVA, post-hoc paired comparisons were performed with the Bonferroni correction. Statistical significance was set at p < 0.05. If normal distribution was not verified, the nparLD module of the R software was used to perform a non-parametric two-way ANOVA-type test and if any significant result was observed, a Friedman test and the post-hoc paired comparisons with the Bonferroni correction as well as a Wilcoxon test were performed. Statistical significance was adjusted according with the number of tests performed for each factor.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lisbon, Portugal, 1495-002 Cruz-Quebrada
- Faculty of Human Kinetics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Football players
- Regularly training with a weekly microcycle consisting of 3 to 5 training sessions and 1 game at the weekend
- Able to provide informed consent
Exclusion Criteria:
- Injury occurrence in the month previous to data collection
- Ergogenic supplements consumption in the month previous to data collection
- Having known intolerance to sodium bicarbonate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Sodium Bicarbonate - Placebo
First exercise performance assessment after ingesting sodium bicarbonate.
Second exercise performance assessment after ingesting placebo
|
Capsules containing 0.3 g/kg of body weight of sodium bicarbonate were ingested in two doses.
The first intake (0.2 g/kg) was performed together with a carbohydrate-enriched meal 2 h before a repeated sprint exercise protocol, and the second (0.1 g/kg) occurred 1 h later.
Capsules containing 0.3 g/kg of body weight of celulose were ingested in two doses.
The first intake (0.2 g/kg) was performed together with a carbohydrate-enriched meal 2 h before a repeated sprint exercise protocol, and the second (0.1 g/kg) occurred 1 h later.
|
|
Experimental: Placebo - Sodium Bicarbonate
First exercise performance assessment after ingesting placebo.
Second exercise performance assessment after ingesting sodium bicarbonate
|
Capsules containing 0.3 g/kg of body weight of sodium bicarbonate were ingested in two doses.
The first intake (0.2 g/kg) was performed together with a carbohydrate-enriched meal 2 h before a repeated sprint exercise protocol, and the second (0.1 g/kg) occurred 1 h later.
Capsules containing 0.3 g/kg of body weight of celulose were ingested in two doses.
The first intake (0.2 g/kg) was performed together with a carbohydrate-enriched meal 2 h before a repeated sprint exercise protocol, and the second (0.1 g/kg) occurred 1 h later.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak power output
Time Frame: 3 minutes through each set of the repeated sprints tasks
|
Watt
|
3 minutes through each set of the repeated sprints tasks
|
|
Mean power output
Time Frame: 3 minutes through each set of the repeated sprints tasks
|
Watt
|
3 minutes through each set of the repeated sprints tasks
|
|
Total Work
Time Frame: 3 minutes through each set of the repeated sprints tasks
|
Joule
|
3 minutes through each set of the repeated sprints tasks
|
|
Sprint Decrement
Time Frame: 3 minutes through each set of the repeated sprints tasks
|
percentage of power decrease
|
3 minutes through each set of the repeated sprints tasks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Countermovement jump height
Time Frame: Before and after each repeated sprints tasks
|
cm
|
Before and after each repeated sprints tasks
|
|
Lactate accumulation
Time Frame: Before the repeated sprints tasks, between sets of the repeated sprints tasks, immediatly after the repeated sprints tasks, 2 minutes after the repeated sprints tasks
|
mmol.L-1
|
Before the repeated sprints tasks, between sets of the repeated sprints tasks, immediatly after the repeated sprints tasks, 2 minutes after the repeated sprints tasks
|
|
Oxygen uptake
Time Frame: 3 minutes through each set of the repeated sprints tasks
|
mL/kg.min
|
3 minutes through each set of the repeated sprints tasks
|
|
carbon dioxide production
Time Frame: 3 minutes through each set of the repeated sprints tasks
|
Total L
|
3 minutes through each set of the repeated sprints tasks
|
|
Ventilation
Time Frame: 3 minutes through each set of the repeated sprints tasks
|
L/min
|
3 minutes through each set of the repeated sprints tasks
|
|
Heart rate
Time Frame: 3 minutes through each set of the repeated sprints tasks
|
bpm
|
3 minutes through each set of the repeated sprints tasks
|
|
Changes in muscle oxygenated haemoglobin
Time Frame: 3 minutes through each set of the repeated sprints tasks
|
Absorvance relative to rest obtained by Near InfraRed Spectroscopy
|
3 minutes through each set of the repeated sprints tasks
|
|
Changes in muscle deoxygenated haemoglobin
Time Frame: 3 minutes through each set of the repeated sprints tasks
|
Absorvance relative to rest obtained by Near InfraRed Spectroscopy
|
3 minutes through each set of the repeated sprints tasks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- RepSprintsSodiumBicarbonate
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sodium Bicarbonate
-
McMaster UniversityNot yet recruitingExercise | Cognition | Lactate | Sodium BicarbonateCanada
-
Hacettepe UniversityRecruitingThe Effects of Sodium Bicarbonate Supplementation on Endurance Performance in Recreational Female RunnersTurkey
-
University of Nove de JulhoMarcelo Martins KalytczakUnknownFatigue | Electromyography | Sodium Bicarbonate | Alkalosis, MetabolicBrazil
-
Palacky UniversityRecruitingAcid Base Imbalance | Sodium Bicarbonate | Sport Performance | Biomechanics | Ergogenic Support | Water SportsCzechia
-
Chinese PLA General HospitalNot yet recruitingSafety | Effectiveness | Ringer Bicarbonate | Elderly Abdominal Surgery
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI); The George Institute; University...RecruitingDietary Sources of Sodium | Population Sodium IntakeNigeria
-
New York City Department of Health and Mental HygieneCompleted
-
University of Lausanne HospitalsHôpital du Valais; Federal Food Safety and Veterinary OfficeCompleted
-
Tongji HospitalNot yet recruitingHemodynamics Instability | Amobarbital Sodium
-
Johns Hopkins Bloomberg School of Public HealthMcCormick Science InstituteCompletedMaintenance of Recommended Sodium IntakeUnited States
Clinical Trials on Sodium Bicarbonate
-
Sheba Medical CenterUnknownExtravasation | InfiltrationIsrael
-
HALEONCompletedGingivitisUnited Kingdom
-
GlaxoSmithKlineCompleted
-
Guy's and St Thomas' NHS Foundation TrustUniversity of PittsburghActive, not recruiting
-
Jennifer Gassman, PhDNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The...CompletedChronic Kidney DiseaseUnited States
-
Wake Forest University Health SciencesCompletedRenal Replacement Therapy | Kidney Failure, AcuteUnited States
-
University of UtahThe University of Utah Center on AgingTerminatedChronic Kidney DiseaseUnited States
-
Kaiser PermanenteCompletedKidney Diseases | Contrast Induced NephropathyUnited States
-
Instituto Nacional de Cardiologia Ignacio ChavezUnknownAcute Kidney FailureMexico
-
Erasmus Medical CenterCompletedChronic Kidney DiseaseNetherlands